LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5308 | 5905 | 0.8981 | 0.8988 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4890 | 5905 | 0.8277 | 0.8263 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1389 | 4322 | 5905 | 0.7319 | 0.7222 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 3455 | 5905 | 0.5850 | 0.5469 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 72 | hr | 1389 | 2573 | 5905 | 0.4351 | 0.3413 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4087 | 5905 | 0.6919 | 0.6763 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 4163 | 5905 | 0.7038 | 0.6883 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 3560 | 5905 | 0.6022 | 0.5678 |
MCF7 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1389 | 3147 | 5905 | 0.5332 | 0.4798 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 2936 | 5905 | 0.4975 | 0.4314 |
MCF7 | GSK 690693 | 10 | uM | LJP5 | 72 | hr | 1389 | 2689 | 5905 | 0.4549 | 0.3704 |
MCF7 | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1491 | 5445 | 0.2737 | 0.0347 |
MCF7 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 679 | 5445 | 0.1248 | -0.3060 |
MCF7 | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 565 | 5445 | 0.1038 | -0.3675 |
MCF7 | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 1389 | 595 | 5445 | 0.1094 | -0.3514 |
MCF7 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 522 | 5445 | 0.0961 | -0.3922 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 72 | hr | 1389 | 444 | 5445 | 0.0814 | -0.4409 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4541 | 5445 | 0.8383 | 0.8287 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4829 | 5445 | 0.8918 | 0.8866 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 4933 | 5445 | 0.9071 | 0.9035 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1389 | 4646 | 5445 | 0.8551 | 0.8471 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1389 | 3759 | 5445 | 0.6907 | 0.6572 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1389 | 760 | 5445 | 0.1389 | -0.2677 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3648 | 5445 | 0.6718 | 0.6343 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1389 | 3406 | 5445 | 0.6268 | 0.5778 |